NEWS

News Articles

GeoVax Expands and Strengthens Intellectual Property Portfolio

March 4, 2021

Filings Made in Corporate Focus Areas of SARS-CoV-2 and Immuno-Oncology Atlanta, GA, March 4, 2021 – GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced the filing of two additional patent applications important to the Company’s key focus on vaccines against SARS-CoV-2…

Read More

Georgia Bio Names 2021 Golden Helix Award Winners

March 3, 2021

Georgia Department of Economic Development’s EJane Caraway and Georgia Research Alliance’s Susan Shows to be Honored ATLANTA, GA (March 3, 2021) – Georgia Bio, the state’s life science trade association, will virtually celebrate its annual Golden Helix Awards on Thursday, April 1st. Georgia Bio is pleased to announce the winners of the 2021 Golden Helix Awards. …

Read More

Biden to announce ‘historic partnership’: Merck will help make Johnson & Johnson coronavirus vaccine, officials say

March 2, 2021

The administration brokered the arrangement amid concerns about Johnson & Johnson’s production delays President Biden will announce Tuesday that pharmaceutical giant Merck will help make Johnson & Johnson’s single-shot coronavirus vaccine — an unusual pact between fierce competitors that could sharply boost the supply of the newly authorized vaccine, according to senior administration officials. The officials, who spoke…

Read More

Covid-19 Vaccines Yield Breakthroughs in Long-Term Fight Against Infectious Disease

March 2, 2021

Researchers in gene-based technology produced a class of vaccines they believe can protect against all manner of outbreaks in the years to come The pandemic has opened a new era for vaccines developed with gene-based technologies, techniques that have long stumped scientists and pharmaceutical companies, suggesting the possibility of future protection against a range of infectious disease.…

Read More

Atlanta-based Task Force for Global Health to help with Covid-19 vaccines around the globe

March 1, 2021

The Centers for Disease Control and Prevention has invested $10.7 million in the Task Force for Global Health to help set up Covid-19 immunization programs in up to 50 low- and middle-income countries and to start a U.S. Covid-19 vaccine information program. Both the CDC and the Task Force for Global Health are based in…

Read More

Medical Device Industry Challenges Misleading Information Campaign About the Safety and Use of Ethylene Oxide in Georgia

March 1, 2021

AdvaMed and Georgia Bio CEOs team up, saying the misinformation could have “deadly consequences” WASHINGTON, D.C. – The CEO of the world’s largest medical technology trade association (AdvaMed) and the CEO of Georgia Bio, a trade association representing life sciences companies in Georgia, have teamed up to challenge misleading information that has been propagated by the media…

Read More